Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
A sting in the tail

Does CVS Group’s share price fall indicate the vets space has lost its shine, asks Ploy Radford

Most people on the planet are mad about animals. Social media users go wild over a cute puppy picture, and investors start salivating over a growing veterinary clinic platform. Or at least they have done, but could things be about to change?

The rising number of companion animals being bred and acquired, the human inability to say no to paying for the best care for their beloved pet, a changing vet workforce that wants to be salaried within a corporate organisation, and advances in animal care techniques have all contributed to the boom in investors hunting down a veterinary clinic platform. Independent Vetcare, for instance, was acquired by EQT last year for a staggering 19x ebitda, if reports are to be believed.  

But the fall in CVS Group’s share price following its latest round of results indicates that things are not looking so cute in the veterinary space. Speaking at the London-listed veterinary services provider’s AGM on the 30 November, chairman Richard Connell admitted that excluding the sales of its Animed Direct division (which sells animal medicines), like-for-like sales were up by just 1.5%. The board of CVS attributed the slowing in growth to the “greater general uncertainty widely evident in the UK economy and some shortage of clinicians in the UK”, with the latter exacerbated by the vote to leave the European Union, it said.

In other words, there actually is a limit to what people will pay for their pooches when economic headwinds are bitter, and there’s no point growing your number of assets if you can’t staff them – and there is a serious staffing problem in the UK.

As a result of Connell’s words, share price at the firm plummeted by 28.1% to 1,010 pence by the end of the day.

Connell said it intends to raise salaries by more than inflation as well as provide more flexible working arrangements to attract more veterinary surgeons and nurses. The salary increases will be funded through price increases, he added. No doubt, because like most veterinary consolidators they have splurged a lot of money on acquisitions (buying 21 new surgeries since the 1 July 2017 alone), as sellers can command punchy prices, they now can’t fund pay rises from their own reserves.

However, given that economic uncertainty has also put customers off, it is a little hard to see how raising prices will help. CVS might as well copy one of its canine customers and start chasing its own tail.

Investors who think the veterinary space promises an easy return would do well to rein in their acquisitive desires and keep a close eye on CVS’s share price.    

 

Posted on: 01/12/2017

Latest news stories

15/06/2018
Albion Capital and Spice Capital have led an investment round for digital mental health company Healios, raising £2.2 million.
13/06/2018
Nordic Capital has agreed to exit its European veterinary business AniCura after four years, selling to Mars Petcare.
12/06/2018
AXA is to sell intermediary Health & Protection Solutions (trading as The Health Insurance Group) to US investors Highbridge Principal Strategies and Madison Dearborn Partners.
12/06/2018
Private equity firm Apposite Capital has raised £144.5 million of capital for Apposite Healthcare Fund II and associated vehicles.
12/06/2018
The leader of NHS Partners Network (NHSPN), which represents private healthcare providers, has welcomed the findings of a Health & Social Care Select Committee report.


Civica






architecture

The term 'future-proof' may be bandied about in health and care, but what do facilities designed to stand the test of time really look like? Sarah Williams takes a look across the sector
Read more


Christie + Co
my images



gender equality

This year's gender pay reporting revealed there is still an issue with equality in health and care. Sarah Williams digs into the numbers, and asks what companies can and should be doing about it
Read more





HealthInvestor blog
As this HealthInvestor UK editor departs the title, she takes a look back on what has changed in UK health and social care in the last six years

Click here to view the Editor's blog


Alcohol abuse in Scotland has cost the country dearly. Will imposing minimum pricing on alcohol have the desired affect on health and social care though? Clare Connell and Freddie Evans of Connell Consulting investigate
This year’s gender pay reporting revealed there is still an issue with equality in health and care. Sarah Williams digs into the numbers, and asks what companies can and should be doing about it
Private equity house August Equity tells Ploy Radford how its strategy of focusing on the smaller end of the mid-market is the best recipe for success
Outcomes First Group is developing pathways of care that will cover a person with special needs for life. CEO Graham Baker tells Ploy Radford how the company is achieving that in a tough funding and recruitment environment
The term ‘future-proof’ may be bandied about in health and care, but what do facilities designed to stand the test of time really look like? Sarah Williams takes a look across the sector

Click here to search all feature articles